41 – 50 of 52
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1999
-
Mark
Radioimmunotherapy using 131I-labeled anti-CD22 monoclonal antibody (LL2) in patients with previously treated B-cell lymphomas
(
- Contribution to journal › Article
- 1997
-
Mark
Extracorporeal whole-blood immunoadsorption enhances radioimmunotargeting of iodine-125-labeled BR96-biotin monoclonal antibody
(
- Contribution to journal › Article
-
Mark
Early prediction of treatment outcome in head and neck cancer with 2-18FDG PET
(
- Contribution to journal › Article
- 1996
-
Mark
Biodistribution and pharmacokinetics of 125I/131I pair-labelled biotinylated chimeric BR96 in colon carcinoma isografted rats
(
- Contribution to journal › Article
-
Mark
Extracorporeal immunoadsorption from whole blood based on the avidin-biotin concept. Evaluation of a new method
(
- Contribution to journal › Article
- 1995
-
Mark
Enhanced radioimmunotargeting of 125I-labeled L6-biotin monoclonal antibody (MAb) by combining preload of cold L6 MAb and subsequent immunoadsorption in rats
(
- Contribution to journal › Article
-
Mark
A Phase I/II Evaluation of Metoclopramide as a Radiosensitiser in Patients with Inoperable Squamous Cell Carcinoma of the Lung
(
- Contribution to journal › Article
- 1994
-
Mark
Radio-immunotherapy dosimetry with special emphasis on SPECT quantification and extracorporeal immuno-adsorption
(
- Contribution to journal › Scientific review
-
Mark
Improving radioimmunotargeting of tumors: the impact of preloading unlabeled L6 monoclonal antibody on the biodistribution of 125I-L6 in rats
(
- Contribution to journal › Article
-
Mark
A general extracorporeal immunoadsorption method to increase tumor-to-tissue ratio
(
- Contribution to journal › Article